No results found for “”
No results found for filter “”
-
Blog articles 14.06.18
My take on Bio2018
A guest blog by Barbara Freischem, EBE Executive Director
Read Article -
Statements & press releases 07.06.18
EFPIA statement on Horizon Europe
EFPIA welcomes the publication today of the Horizon Europe research framework programme and its specific health cluster in the Global Challenges pillar....
Read Article -
Blog articles 07.06.18
Older how? Ageing projections, technology and the sustainability of European healthcare
If most of us will live until 100 years or more, how will those last 10-20 years look like? The answer to that question is maybe the most important for...
Read Article -
Blog articles 31.05.18
Three thoughts from SPIEF 2018
Nathalie Moll and Koen Berden share their reflections on the St. Petersburg International Economic Forum (SPIEF)
Read Article -
Statements & press releases 28.05.18
EFPIA statement on the Commission’s proposal to introduce an SPC manufacturing waiver, weakening Europe’s...
EFPIA, the organisation representing 40 of the biggest investors in life science research and development is deeply concerned with the European Commission’s...
Read Article -
EFPIA News 22.05.18
Job vacancy: Senior Manager Public Affairs
The Senior Manager Public Affairs coordinates and leads on a number of priority dossiers in the organisation’s strategic advocacy and outreach activities...
Read Article -
EFPIA News 22.05.18
Job vacancy: Manager Public Affairs
The Manager Public Affairs supports the Public Affairs Team in the execution of the organisation’s advocacy and outreach activities related to legislation...
Read Article -
Blog articles 22.05.18
Unlocking tomorrow’s cures: sharing the medicines development story in the European Parliament
An exhibition to explore the cutting-edge science behind new treatments and how it is transforming patients’ lives
Read Article -
Blog articles 18.05.18
Evolving our approach to clinical trials
A blog by EFPIA President Stefan Oschmann
Read Article -
Blog articles 17.05.18
Inspiration, innovation and collaboration
Reflections on ECRD 2018
Read Article -
Blog articles 16.05.18
Leading the way on innovation and regulation in biomanufacturing
A guest blog by Barbara Freischem, EBE Executive Director
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 22.05.18
Job vacancy: Senior Manager Public Affairs
The Senior Manager Public Affairs coordinates and leads on a number of priority dossiers in the organisation’s strategic advocacy and outreach activities...
Read Article -
EFPIA News 22.05.18
Job vacancy: Manager Public Affairs
The Manager Public Affairs supports the Public Affairs Team in the execution of the organisation’s advocacy and outreach activities related to legislation...
Read Article -
EFPIA News 08.05.18
EFPIA position on proposal for a Regulation of the European Parliament and the Council on HTA and amending...
This paper outlines EFPIA’s views on the four pillars of EU HTA cooperation included in the Commission proposal
Read Article -
EFPIA News 03.05.18
Early Career Research Prize in Vaccinology R&D – 2nd edition
Promote and foster a younger generation of scientists in the early stages of their career!
Read Article -
EFPIA News 03.07.17
EFPIA-College of Europe Prize
The 2017 Laureat of the EFPIA-College of Europe Prize is Luca Deplano
Read Article -
EFPIA News 30.05.17
Final Call ATMP Survey
Help improve product development and regulation
Read Article -
EFPIA News 24.04.17
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European...
Read Article -
EFPIA News 19.04.17
EPAA Refinement Prize 2017
Call for Submissions
Read Article -
EFPIA News 31.03.17
Open Invitation for ATMP-developers
To help improve product development and its regulation
Read Article -
EFPIA News 01.03.17
New project: success and failure in the development and commercialisation of ATMP products
A Lygature’s project
Read Article -
EFPIA News 20.02.17
Joint Declaration on EU Industrial Strategy
Read Article -
EFPIA News 15.12.16
EFPIA opinion on Health at a Glance: Europe 2016
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 07.06.18
EFPIA statement on Horizon Europe
EFPIA welcomes the publication today of the Horizon Europe research framework programme and its specific health cluster in the Global Challenges pillar....
Read Article -
Statements & press releases 28.05.18
EFPIA statement on the Commission’s proposal to introduce an SPC manufacturing waiver, weakening Europe’s...
EFPIA, the organisation representing 40 of the biggest investors in life science research and development is deeply concerned with the European Commission’s...
Read Article -
Statements & press releases 04.05.18
The Common Market of Medicines within the Eurasian Economic Union was presented in the European Union...
The EAEU common market, regulating the circulation of medicines in the Union, was officially presented in Brussels on 25 April 2018
Read Article -
Statements & press releases 04.05.18
EFPIA statement on the EU Multiannual Financial Framework 2021-2027
We recognise the significant number of priorities the Commission is seeking to address through the MFF and want to underline the importance of health and...
Read Article -
Statements & press releases 25.04.18
EFPIA welcomes the publication of the European Commission Communication on digital transformation of...
Digital technologies have the potential to help transform the way novel medicines are discovered, developed and delivered to patients
Read Article -
Statements & press releases 17.04.18
EFPIA opinion on European Semester Country Reports
The Country Reports review economic and social developments, challenges and opportunities in the Member States and form the basis of a dialogue between...
Read Article -
Statements & press releases 16.04.18
EFPIA/CPIA Joint China/EU Pharmaceutical Industry Forum to Explore New Frontiers in Pharmaceutical Regulation...
Its aim is to showcase major developments in four key pharmaceutical policy areas: pharmaceuticals in the environment (PiE); coding and serialisation;...
Read Article -
Statements & press releases 10.04.18
PARADIGM, a unique collaboration for better patient engagement in medicines development kicks off with...
PARADIGM stands for Patients Active in Research and Dialogues for an Improved Generation of Medicines and is funded by the Innovative Medicines Initiative...
Read Article -
Statements & press releases 10.04.18
Joint Declaration on Pharmaceuticals in the Environment
We, the signatories of this declaration, recognise and understand the concerns regarding the presence of pharmaceuticals in the environment.
Read Article -
Statements & press releases 03.04.18
EFPIA statement in response to The Times article on disclosure
Scientific exchange between industry and the medical community is vital for advancement of patient care. It is a relationship that has delivered numerous...
Read Article -
Statements & press releases 23.03.18
Statement in response to the EU Council ratifying the Brexit transition deal
The associations representing the European and British life science industry have today responded to the European Council approving terms of the transition...
Read Article -
Statements & press releases 08.03.18
European health community issues key questions Article 50 negotiations must answer for patients and public...
The European Health Community has warned that time is running out to secure patients’ interests in Brexit negotiations
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 14.06.18
My take on Bio2018
A guest blog by Barbara Freischem, EBE Executive Director
Read Article -
Blog articles 07.06.18
Older how? Ageing projections, technology and the sustainability of European healthcare
If most of us will live until 100 years or more, how will those last 10-20 years look like? The answer to that question is maybe the most important for...
Read Article -
Blog articles 31.05.18
Three thoughts from SPIEF 2018
Nathalie Moll and Koen Berden share their reflections on the St. Petersburg International Economic Forum (SPIEF)
Read Article -
Blog articles 22.05.18
Unlocking tomorrow’s cures: sharing the medicines development story in the European Parliament
An exhibition to explore the cutting-edge science behind new treatments and how it is transforming patients’ lives
Read Article -
Blog articles 18.05.18
Evolving our approach to clinical trials
A blog by EFPIA President Stefan Oschmann
Read Article -
Blog articles 17.05.18
Inspiration, innovation and collaboration
Reflections on ECRD 2018
Read Article -
Blog articles 16.05.18
Leading the way on innovation and regulation in biomanufacturing
A guest blog by Barbara Freischem, EBE Executive Director
Read Article -
Blog articles 03.05.18
Nailing down the Future
"If all you have is a hammer, everything looks like a nail". In the hardware shop of data and digital policy, the hammer is regulation and the nail……….well,...
Read Article -
Blog articles 03.05.18
Poland carries the Torch
Celebrating some of the many world’s scientific giants who lit the torch that we carry in the Innovative Medicines Initiative
Read Article -
Blog articles 26.04.18
Here’s to the creators and inventors of tomorrow (Guest Blog)
World Intellectual Property Day celebrate the women and men who every day do their best to push back the frontiers of arts and sciences
Read Article -
Blog articles 26.04.18
World IP Day: One of the Most Important Health Observance Days of the Year
Intellectual property (IP) is a cornerstone of creating new therapies and addressing unmet medical needs for everyone
Read Article -
Blog articles 26.04.18
Sustainable innovation and the need for a carefully balanced intellectual property incentives system...
The extensive range of new medicines that is available today and in the pipeline for tomorrow would not be there without robust IP protection
Read Article